These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6112221)

  • 1. Glutathione turnover in human erythrocytes. Inhibition by buthionine sulfoximine and incorporation of glycine by exchange.
    Griffith OW
    J Biol Chem; 1981 May; 256(10):4900-4. PubMed ID: 6112221
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma glutathione turnover in the rat: effect of fasting and buthionine sulfoximine.
    Hum S; Robitaille L; Hoffer LJ
    Can J Physiol Pharmacol; 1991 May; 69(5):581-7. PubMed ID: 1863907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).
    Griffith OW; Meister A
    J Biol Chem; 1979 Aug; 254(16):7558-60. PubMed ID: 38242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of depletion of glutathione by buthionine sulfoximine on lipid peroxidation in rats acutely treated with ethanol.
    Koçak-Toker N; Mutlu-Türkoğlu U; Alptekin N; Uysal M
    Int J Biochem; 1993 Dec; 25(12):1765-8. PubMed ID: 8138014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Origin and turnover of mitochondrial glutathione.
    Griffith OW; Meister A
    Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4668-72. PubMed ID: 3860816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis.
    Griffith OW
    J Biol Chem; 1982 Nov; 257(22):13704-12. PubMed ID: 6128339
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of glutathione turnover in drug sulfation: differential effects of diethylmaleate and buthionine sulfoximine on the pharmacokinetics of acetaminophen in the rat.
    Galinsky RE
    J Pharmacol Exp Ther; 1986 Jan; 236(1):133-9. PubMed ID: 3941389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular glutathione contents in isolated hepatocytes treated with L-buthionine sulfoximine.
    Romero FJ; Sies H
    Biochem Biophys Res Commun; 1984 Sep; 123(3):1116-21. PubMed ID: 6487323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased excitotoxic vulnerability of cortical cultures with reduced levels of glutathione.
    Bridges RJ; Koh JY; Hatalski CG; Cotman CW
    Eur J Pharmacol; 1991 Jan; 192(1):199-200. PubMed ID: 1674918
    [No Abstract]   [Full Text] [Related]  

  • 10. Buthionine sulfoximine reduces the protective capacity of myocytes to withstand peroxide-derived free radical attack.
    Le CT; Hollaar L; van der Valk EJ; van der Laarse A
    J Mol Cell Cardiol; 1993 May; 25(5):519-28. PubMed ID: 8104252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of prolonged treatment with L,S-buthionine sulfoximine.
    Malaker K; Hurwitz SJ; Bump EA; Griffith OW; Lai LL; Riese N; Coleman CN
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):407-12. PubMed ID: 7910818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of buthionine sulfoximine, an inhibitor of glutathione biosynthesis, on the selenium-induced lethality in mice.
    Ishikawa M; Takayanagi G; Sasaki K
    Jpn J Pharmacol; 1988 Oct; 48(2):283-6. PubMed ID: 3210451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of glutathione synthesis in the liver leads to S-adenosyl-L-methionine synthetase reduction.
    Corrales F; Ochoa P; Rivas C; Martin-Lomas M; Mato JM; Pajares MA
    Hepatology; 1991 Sep; 14(3):528-33. PubMed ID: 1874498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked reduction of rat brain glutathione following intracerebroventricular administration of the glutathione synthesis inhibitor L-buthionine sulfoximine.
    Pileblad E; Magnusson T
    Neurosci Lett; 1988 Dec; 95(1-3):302-6. PubMed ID: 3226616
    [No Abstract]   [Full Text] [Related]  

  • 15. Glutathione levels in human platelets display a circadian rhythm in vitro.
    Radha E; Hill TD; Rao GH; White JG
    Thromb Res; 1985 Dec; 40(6):823-31. PubMed ID: 4089839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of glutathione by inhibition of biosynthesis.
    Griffith OW
    Methods Enzymol; 1981; 77():59-63. PubMed ID: 6120437
    [No Abstract]   [Full Text] [Related]  

  • 17. Analytical and preparative separation of the diastereomers of L-buthionine (SR)-sulfoximine, a potent inhibitor of glutathione biosynthesis.
    Campbell EB; Hayward ML; Griffith OW
    Anal Biochem; 1991 May; 194(2):268-77. PubMed ID: 1677799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione biosynthesis and its inhibition.
    Meister A
    Methods Enzymol; 1995; 252():26-30. PubMed ID: 7476360
    [No Abstract]   [Full Text] [Related]  

  • 19. The deleterious effect of buthionine sulfoximine, a glutathione-depleting agent, on the cisplatin toxicity in mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Jpn J Pharmacol; 1990 Apr; 52(4):652-5. PubMed ID: 2342233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of buthionine sulfoximine, an inhibitor of glutathione synthesis, on hepatic drug metabolism in the male mouse.
    White RD; Norton R; Bus JS
    Toxicol Lett; 1984 Oct; 23(1):25-32. PubMed ID: 6485015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.